Cervical cancer : Promoter hypermethylation and its reversal 

Journal Title: Journal of Pharmacy Research - Year 2011, Vol 4, Issue 10

Abstract

Cervical cancer is one of the most common cancer in women resulting in 0.4% of the total mortality across the world. A number of epigenetic alterations occur during all stages of cervical carcinogenesis including global DNA hypomethylation, hypermethylation of the tumor suppressor genes, and histone modifications, like acetylation, deacetylation, phosphorylation, methylation etc. Many genetic and environmental factors lead to the development of cervical cancer, but DNA methylation may provide a link between these factors. Genome stability and normal gene expression are largely maintained by a fixed and predetermined pattern of DNA methylation. The reversible nature of epigenetic changes constitutes a target for transcriptional therapies, namely DNA methylation and histone deacetylase inhibitors. The near future is likely to bring long-awaited answers on the impact of aberrant epigenetic information caused by diet and environment and provide important information for the discovery of new biomarkers andthe development of novel strategies for diagnosis and prevention, of cervical cancer which is the most common cancer affecting developing nations. This review encompasses the epigenetics of cervical cancer and the recent discoveries till now in the field of the reversal of epigenetic changes, which in turn would lead to a significant step in the direction of therapy against this dreaded disease. 

Authors and Affiliations

Abhimanyu Kumar Jha 1 , 2 , Mo h s e n Ni k b a k h t 1 , Ne e n a Ca p a l a s h 1 q , Jagde ep Kaur 1 * q

Keywords

Related Articles

Synthesis, spectroscopic characterisation, antimicrobial and larvicidal studies of some transition metal complexes derived from tetradentate Schiff base ligand 

In the present work the Schiff base ligand was synthesised by condensation of 2,6-diaminopyridine with salicylaldehyde in 1:2 molar ratio to give N,N’-bis (salicylidene)-2,6- diaminopyridine (H 2 L).The transition met...

Estimation of Bambuterol in tablet dosage forms by RP-HPLC

A simple, precise, rapid and accurate reverse phase HPLC method was developed for the estimation of Bambuterol in tablet dosage forms. An Inertsil ODS-3CV C18, 250x4.6 mm, coloumn with 5 µm particle size and the mobile p...

Formulation and Evaluation of Mesalamine Microspheres for Colon Targeted Drug Delivery System

Mesalamine (5-ASA) is an anti-inflammatory drug used in treatment of Crohn’sdisease and ulcerative-colitis. As Mesalamine is rapidly absorbed from the small intestine and it is necessary to develop a colon-specific deliv...

Benzimidazole compounds: As antimicrobial agents 

Heterocyclic compounds exhibited remarkable pharmacological activities. Literature indicates that compounds of pyrimidine, pyridine, benzimidazole nucleus have wide range of therapeutic uses such as antitubercular, anti...

Chiral switches: A Review

Chiral drug are made up of molecule with the same chemical structure, but different three-dimensional arrangements. Modern manufacturing has enabled the development of products containing a single molecular arrangement....

Download PDF file
  • EP ID EP86639
  • DOI -
  • Views 101
  • Downloads 0

How To Cite

Abhimanyu Kumar Jha 1, 2, Mo h s e n Ni k b a k h t 1, Ne e n a Ca p a l a s h 1 q, Jagde ep Kaur 1 * q (2011). Cervical cancer : Promoter hypermethylation and its reversal . Journal of Pharmacy Research, 4(10), 3378-3382. https://europub.co.uk/articles/-A-86639